Risk factors and drug resistance in early-onset neonatal group B streptococcal disease

Autor: Yao-Qiang Du, Guang-yong Ye, Yi-Yun Wang, Ying-Wei Wang, Dong Chen, Yun-Zhong Jing, Yu Tong, Mei-Qin Zheng, Kai Xu, Xiaolin Miao, Zhen Wang, Ai-Bo Xu
Rok vydání: 2018
Předmět:
0301 basic medicine
Adult
Pediatrics
medicine.medical_specialty
China
Drug Resistance
Mothers
Drug resistance
Disease
medicine.disease_cause
General Biochemistry
Genetics and Molecular Biology

Group B
Streptococcus agalactiae
03 medical and health sciences
0302 clinical medicine
Pregnancy
Risk Factors
Streptococcal Infections
Drug Resistance
Bacterial

Correspondence
medicine
Humans
030212 general & internal medicine
General Pharmacology
Toxicology and Pharmaceutics

Risk factor
Pregnancy Complications
Infectious

Pathogen
reproductive and urinary physiology
Lung
General Veterinary
Genitourinary system
Streptococcus
business.industry
Incidence
General Medicine
bacterial infections and mycoses
Anti-Bacterial Agents
Parity
030104 developmental biology
medicine.anatomical_structure
bacteria
Female
business
Zdroj: Journal of Zhejiang University. Science. B. 19(12)
ISSN: 1862-1783
Popis: In recent years, group B streptococcus (GBS) has become an important pathogen that causes infections in many neonatal organs, including the brain, lung, and eye (Ballard et al., 2016). A series of studies performed on GBS infections in western countries have revealed that GBS is one of the primary pathogens implicated in perinatal infection, and GBS infections are a major cause of neonatal morbidity and mortality in the United States (Decheva et al., 2013). In China, GBS is mainly found by screens for adult urogenital tract and perinatal infections, and neonatal GBS infections have been rarely reported. The incidence rate of early-onset neonatal GBS disease is thought to be lower in China than in western countries; however, this data is controversial since it also reflects the clinical interest in GBS (Dabrowska-Szponar and Galinski, 2001).
Databáze: OpenAIRE